These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15769738)

  • 1. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
    Ioannidis P; Mahaira LG; Perez SA; Gritzapis AD; Sotiropoulou PA; Kavalakis GJ; Antsaklis AI; Baxevanis CN; Papamichail M
    J Biol Chem; 2005 May; 280(20):20086-93. PubMed ID: 15769738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
    Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
    J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary tumor induction in transgenic mice expressing an RNA-binding protein.
    Tessier CR; Doyle GA; Clark BA; Pitot HC; Ross J
    Cancer Res; 2004 Jan; 64(1):209-14. PubMed ID: 14729626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer.
    Dimitriadis E; Trangas T; Milatos S; Foukas PG; Gioulbasanis I; Courtis N; Nielsen FC; Pandis N; Dafni U; Bardi G; Ioannidis P
    Int J Cancer; 2007 Aug; 121(3):486-94. PubMed ID: 17415713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells.
    Katsara O; Mahaira LG; Iliopoulou EG; Moustaki A; Antsaklis A; Loutradis D; Stefanidis K; Baxevanis CN; Papamichail M; Perez SA
    Stem Cells Dev; 2011 Sep; 20(9):1549-61. PubMed ID: 21204633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells.
    Fakhraldeen SA; Clark RJ; Roopra A; Chin EN; Huang W; Castorino J; Wisinski KB; Kim T; Spiegelman VS; Alexander CM
    J Biol Chem; 2015 May; 290(21):13386-400. PubMed ID: 25861986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
    Mehmood K; Akhtar D; Mackedenski S; Wang C; Lee CH
    Mol Pharmacol; 2016 Jun; 89(6):606-17. PubMed ID: 27036131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
    Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
    Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking.
    Nielsen FC; Nielsen J; Christiansen J
    Scand J Clin Lab Invest Suppl; 2001; 234():93-9. PubMed ID: 11713986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressive lipoxygenases inhibit the expression of c-myc mRNA coding region determinant-binding protein/insulin-like growth factor II mRNA-binding protein 1 in human prostate carcinoma PC-3 cells.
    Kawakami Y; Kubota N; Ekuni N; Suzuki-Yamamoto T; Kimoto M; Yamashita H; Tsuji H; Yoshimoto T; Jisaka M; Tanaka J; Fujimura HF; Miwa Y; Takahashi Y
    Biosci Biotechnol Biochem; 2009 Aug; 73(8):1811-7. PubMed ID: 19661680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
    Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
    Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells.
    Liao B; Hu Y; Herrick DJ; Brewer G
    J Biol Chem; 2005 May; 280(18):18517-24. PubMed ID: 15753088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor receptor profile of CD34 cells in normal bone marrow, cord blood and mobilized peripheral blood.
    De Waele M; Renmans W; Asosingh K; Vander Gucht K; Van Riet I
    Eur J Haematol; 2004 Mar; 72(3):193-202. PubMed ID: 14962238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells.
    Wagner-Souza K; Diamond HR; Ornellas MH; Gomes BE; Almeida-Oliveira A; Abdelhay E; Bouzas LF; Rumjanek VM
    Int J Mol Med; 2008 Aug; 22(2):237-42. PubMed ID: 18636179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
    Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene and miRNA expression profiles of hematopoietic progenitor cells vary depending on their origin.
    Báez A; Martín-Antonio B; Piruat JI; Barbado MV; Prats C; Álvarez-Laderas I; Carmona M; Pérez-Simón JA; Urbano-Ispizua Á
    Biol Blood Marrow Transplant; 2014 May; 20(5):630-9. PubMed ID: 24462744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.